Even as weight-loss drugs such as Wegovy and Zepbound explode in popularity, many Americans struggle to afford them.

As the Biden administration is proposing drugs like Ozempic and Wegovy be covered by Medicare and Medicaid, Black people need ...

Biden’s Center for Medicare and Medicaid Services extends coverage by making nonsense of the law.

The Biden administration is looking to expand access to anti-obesity GLP-1 drugs like Ozempic and Wegovy for people who have ...

Medicare has been barred from offering the drugs ... approving a new class of weekly injectables like Novo Nordisk's Wegovy and Eli Lilly's Zepbound to treat obesity. People can lose as much ...

If the proposal is finalized, it could set the stage for a showdown between the pharmaceutical industry and the Trump ...

Later, Wegovy, a higher-dose version of semaglutide ... According to a fact sheet from the White House, approximately 3.4 million Medicare beneficiaries and 4 million Medicaid recipients would gain ...

Medicare, the federal health program for adults ... West Virginia resident Debbie Halstead worries the cost of her weight-loss drug Wegovy will no longer be affordable due to a change in insurance ...

Washington — Millions of Americans with obesity would be eligible to have popular drugs used for weight loss like Wegovy or Ozempic covered by Medicare and Medicaid under a new rule the Biden ...

The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid ...

Medicare, the federal health program for adults ... the financial crunch she'll face when the calendar flips to January. Wegovy's manufacturer, Novo Nordisk, offers a $225 coupon that would ...